360 participants, 8 centres, 2 groups
The study will capture data – under the primary endpoints – virus neutralising antibodies against SARS-CoV-2 at baseline and again at 28 days post booster dose. Representational image. AP India…
Share
Posts by tag
Input your search keywords and press Enter.